2013 ASH Annual Meeting and Exposition- KEY ABSTRACTS for Myeloproliferative Neoplasms
December 7-10, 2013 – Ernest N. Morial Convention Center, New Orleans, LA
Myeloproliferative Neoplasms Absracts
-
- Frequent Mutations in the Calreticulin Gene CALR in Myeloproliferative Neoplasms
- The Genomic Landscape of Myeloproliferative Neoplasms: Somatic Calr Mutations in the Majority of JAK2-Wildtype Patients
- Increased Platelet Thrombus Formation Under Flow Condition In Myeloproliferative Neoplasms (MPN)
- Update On The Long-Term Efficacy and Safety Of Momelotinib, a JAK1 and JAK2 Inhibitor, For The Treatment Of Myelofibrosis
